Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CoVLP (trivalent)
- Development stage
- Unknown
- Lead developer
- Medicago
- Modality
- Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
CoVLP (trivalent) is an enveloped virus-like particle (eVLP) vaccine candidate developed by Sferogen for the prevention of COVID-19. The vaccine is produced using Sferogen's eVLP platform, which generates non-infectious particles that mimic the structural characteristics of the SARS-CoV-2 virus. By presenting viral antigens in this native-like conformation, the vaccine is designed to elicit robust neutralizing antibody and T-cell immune responses. As a trivalent formulation, it is intended to provide broad protection against multiple variants of the SARS-CoV-2 virus. The candidate is currently in Phase 1 clinical development.
- Other names
- CoVLP-Sferogen-SARS-CoV-2-enveloped virus-like particle (eVLP) vaccine-COVID-19eVLP/SARS-CoV-2 vaccine
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on CoVLP (trivalent).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CoVLP (trivalent).